@article{a806556c25d6404998484e32940ff5a5,
title = "KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial",
keywords = "Humans, Child, Prospective Studies, Hematopoietic Stem Cell Transplantation, Transplantation Conditioning, Graft vs Host Disease/etiology, Receptors, KIR, Myelodysplastic Syndromes/therapy, Leukemia, Myeloid, Acute/therapy, Antigens, CD19, Receptors, Antigen, T-Cell, alpha-beta",
author = "Pulsipher, \{Michael A.\} and Ahn, \{Kwang W.\} and Bunin, \{Nancy J.\} and Nahal Lalefar and Eric Anderson and Allyson Flower and Cairo, \{Mitchell S.\} and Talano, \{Julie An\} and Sonali Chaudhury and Kitko, \{Carrie L.\} and Duke, \{Jamie L.\} and Dimitrios Monos and Wing Leung and Dvorak, \{Christopher C.\} and Hisham Abdel-Azim",
note = "{\textcopyright} 2022 by The American Society of Hematology.",
year = "2022",
month = dec,
day = "15",
doi = "10.1182/blood.2022015959",
language = "English",
volume = "140",
pages = "2556--2572",
journal = "Blood",
issn = "0006-4971",
number = "24",
}